Taste, Smell Disturbances Seen in GLP-1 Users
Diabetes patients using GLP-1 agents had a higher risk of smell and taste disturbances over 2 years, though absolute risk increases were very small. Smell disturbances included anosmia and parosmia;…
GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
CHICAGO — Use of GLP-1 receptor agonists was tied to significantly lower risks of major diabetic foot complications compared with SGLT2 inhibitors in adults with type 2 diabetes, a large,…
